Webinar: Lessons Learned from 2020 Provide a Springboard for Increased Telehealth Adoption - POCTRN

null Webinar: Lessons Learned from 2020 Provide a Springboard for Increased Telehealth Adoption

Webinar: Lessons Learned from 2020 Provide a Springboard for Increased Telehealth Adoption

Healthcare providers, payers, suppliers and innovators, and patients all have a role, a choice to make telehealth part of the solution.


In 2020, telehealth was on the top of a mountain. The virtual visit became a universally understood concept and for the first time in history, patients experienced the convenience of having the doctor’s office brought into their home. However, common themes are emerging that could bring us back to an in-person-dominant care model, including the threat of lower reimbursement for telehealth visits compared to in-person. The choices we make in the next few months will determine the landscape for telehealth in the US for at least a decade. For telehealth to survive, we must create logical, financially sound reasons for providers to pivot long term. Simply saying that telehealth is the right thing to do or that patients demand it does not seem good enough as we look at our future. Healthcare providers, payers, suppliers and innovators, and patients all have a role, a choice to make telehealth part of the solution.

Speaker: 
Joseph C. Kvedar, MD
President and Chairman of the Board, American Telehealth Association
Editor-in-Chief, Digital Medicine
Senior Advisor, Center for Innovation in Digital HealthCare, Mass General Brigham

When:
October 19, 2021 
2PM ET

Watch the Webinar >

RADx: Rapid Acceleration of Diagnostics

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADxsm) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.

ABOUT RADx

In the News 

Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration

New HHS actions add to Biden administration efforts to increase access to easy-to-use over-the-counter COVID-19 tests

NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests

The need for new test verification and regulatory support for innovative diagnostics

NIH-funded screening study builds case for frequent COVID-19 antigen testing

RADx partnerships speed new COVID testing

One Year of RADx Tech Success

Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort 

Innovative COVID-19 Testing RADx Tech Reports Unveiled in Special Issue of IEEE Open Journal of Engineering in Medicine and Biology

Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test

RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing

COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative

NIH Director: Collaboration Amid Chaos, and Biden’s First 100 Days - How Francis Collins sees the COVID response changing with the new administration

The National Strategy From the COVID-19 Response and Pandemic Preparedness

Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced

The Need for More and Better Testing for COVID-19